Interventional cardiology devices are medical devices used in the diagnosis and treatment of cardiovascular disease. These devices are used in minimally invasive procedures that are performed through a small incision or puncture, rather than through open surgery. According to the latest research, the interventional cardiology devices market in Brazil is poised to grow by USD 80.2 million during 2023-2029, progressing at a CAGR of 5.2% during the forecast period. Minimally invasive procedures are becoming increasingly popular among patients and healthcare providers, as they offer several benefits over traditional open surgery, such as reduced risk of infection, shorter hospital stays, and faster recovery times. Interventional cardiology devices are often used in minimally invasive procedures, which is driving demand for these devices.
This industry report offers market estimates of the Brazil market, followed by a detailed analysis of the product. The Brazil market data on interventional cardiology devices can be segmented by product: cardiac catheters, coronary guidewires, coronary stents (bare metal stents, bioabsorbable stents, covered stents and drug eluting stents), intravascular ultrasound systems (IVUS), PTCA balloon catheters. The coronary stents segment held the largest share of the Brazil interventional cardiology devices market in 2022 and is anticipated to hold its share during the forecast period.
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleWe are friendly and approachable, give us a call.